HR2202-119

Introduced

To prohibit taxpayer-funded gender transition procedures, and for other purposes.

119th Congress Introduced Mar 18, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill prohibits all federal funds from being used for gender transition procedures, including surgeries and hormone therapies. It also prevents federal premium tax credits and cost-sharing reductions under the Affordable Care Act from being used to purchase health insurance plans that cover gender transition procedures.

Who Benefits and How

  • Taxpayers opposed to funding gender transition procedures: Federal tax dollars will no longer fund these procedures through any federal program, including Medicaid matching funds.
  • Health insurance companies offering plans without gender transition coverage: These plans remain eligible for ACA premium tax credits and subsidies, potentially gaining market share.

Who Bears the Burden and How

  • Transgender individuals seeking gender transition care: Must pay entirely out-of-pocket for procedures, or purchase separate coverage with non-federal funds; lose access to federally-subsidized coverage.
  • Healthcare providers specializing in gender transition services: Face reduced patient base as federal funding and ACA subsidies no longer cover these services.
  • Federal employees and military personnel seeking these procedures: Cannot access these services through federal health facilities or federal employee health plans.

Key Provisions

  • Prohibits all federal funds from being spent on gender transition procedures (Section 301)
  • Prohibits federal funds from being spent on health insurance that covers gender transition procedures (Section 302)
  • Bars federal health facilities and federal employees from providing these services (Section 303)
  • Excludes health plans covering gender transition procedures from ACA premium tax credits (Section 201)
  • Defines gender transition procedures extensively, including hormones, puberty blockers, and various surgical procedures (Section 307)

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.

At a Glance

What This Bill Does

Prohibits the use of federal funds for gender transition procedures and excludes health plans covering such procedures from receiving federal premium tax credits or cost-sharing reductions under the Affordable Care Act.

Key Policy Areas

Healthcare, Federal Spending, Tax Policy

Primary Purpose

Prohibits the use of federal funds for gender transition procedures and excludes health plans covering such procedures from receiving federal premium tax credits or cost-sharing reductions under the Affordable Care Act.

Policy Domains

Healthcare Federal Spending Tax Policy

Title I - Prohibiting Taxpayer-Funded Gender Transition Procedures

Identified Gains
Contextual inference, no direct clause citation
  • Taxpayers opposed to funding gender transition procedures
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • Transgender individuals seeking federally-funded healthcare
  • Healthcare providers offering gender transition services
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Title II - Clarifying Application to ACA

Identified Gains
Contextual inference, no direct clause citation
  • Health insurers offering plans without gender transition coverage
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • ACA marketplace enrollees seeking gender transition coverage
  • Health insurers offering comprehensive gender-affirming care plans
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

New Chapter 4 of Title 1 USC - Core Prohibitions

Identified Gains
Contextual inference, no direct clause citation
  • Federal budget
  • Taxpayers
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • Transgender individuals
  • Gender-affirming healthcare providers
  • Federal health facilities
Model: N/A | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Legislative Progress

Introduced
Introduced Committee Passed
Mar 18, 2025

Mr. LaMalfa introduced the following bill; which was referred to …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Healthcare
12 mentions across 6 clauses
-12 negative

ACA marketplace enrollees seeking gender-affirming coverage, Federal employees enrolled in FEHB plans with gender-affirming coverage, Federal employees providing healthcare services

Financial Services
10 mentions across 6 clauses
+5 positive -4 negative ?1 uncertain

Federal healthcare programs (Medicare, Medicaid, TRICARE), Health insurance companies offering gender-affirming coverage, Health insurance companies offering standalone gender-affirming plans

Positive-direction: Federal healthcare programs (Medicare, Medicaid, TRICARE), Health insurance companies offering standalone gender-affirming plans, Health insurers offering ACA plans without gender-affirming coverage, Health insurers offering plans without gender-affirming coverage, Private health insurance companies

Negative-direction: Health insurance companies offering gender-affirming coverage, Health insurers offering ACA plans with gender-affirming coverage, Health insurers offering federally-subsidized plans with gender-affirming coverage, State Medicaid programs

Manufacturing
1 mention across 1 clause
-1 negative

Pharmaceutical manufacturers of puberty blockers and hormone therapies

Taxpayers
1 mention across 1 clause
+1 positive

Taxpayers opposed to funding gender transition procedures

State & Local Government
1 mention across 1 clause
-1 negative

State governments contracting for health coverage

Small Business
1 mention across 1 clause
-1 negative

Small employers offering health plans with gender-affirming coverage

Government
1 mention across 1 clause
-1 negative

Office of Personnel Management (OPM) overseeing multi-state plans

10/11
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Federal Spending
Domains
Tax Policy Healthcare
Domains
Healthcare Federal Spending

Key Definitions

Terms defined in this bill

3 terms
"gender transition procedure" §307

Any hormonal or surgical intervention for the purpose of gender transition, including puberty blockers, hormone therapy, castration, hysterectomy, mastectomy, phalloplasty, vaginoplasty, and various other surgical procedures

"female" §307_female

An individual who naturally has, had, will have, or would have, but for a congenital anomaly, historical accident, or intentional or unintentional disruption, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization

"gender transition" §307_gender_transition

The process in which an individual goes from identifying with or presenting as his or her sex to identifying with or presenting a self-proclaimed identity that does not correspond with or is different from his or her sex

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology